UNICANCER-PEGASE 07 study: a randomized phase III trial evaluating postoperative docetaxel-5FU regimen after neoadjuvant dose-intense chemotherapy for treatment of inflammatory breast cancer.
PubWeight™: 0.90‹?›
Published in Ann Oncol on May 05, 2015
Authors
A Gonçalves1, J-Y Pierga2, J-M Ferrero3, M-A Mouret-Reynier4, T Bachelot5, R Delva6, M Fabbro7, F Lerebours8, J-P Lotz9, C Linassier10, N Dohollou11, J-C Eymard12, B Leduc13, J Lemonnier14, A-L Martin14, J-M Boher1, P Viens15, H Roché16
Author Affiliations
1: Department of Medical Oncology, Institut Paoli-Calmettes, Marseille Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS 7258, Aix-Marseille Univ, Marseille.
2: Department of Medical Oncology, Institut Curie, Université Paris Descartes, Paris.
3: Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France.
4: Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand.
5: Department of Medical Oncology, Centre Léon Bérard, Lyon.
6: Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Angers.
7: Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier.
8: Department of Medical Oncology, Institut Curie, Hôpital René Huguenin, Saint-Cloud.
9: Department of Medical Oncology, Hôpital Tenon, Paris.
10: Department of Medical Oncology, CHU, Tours.
11: Department of Medical Oncology, Polyclinique Bordeaux Nord-Aquitaine, Bordeaux.
12: Department of Medical Oncology, Institut Jean Godinot, Reims.
13: Department of Medical Oncology, CHG, Brive-la-Gaillarde.
14: Unicancer, Paris.
15: Department of Medical Oncology, Institut Paoli-Calmettes, Marseille Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS 7258, Aix-Marseille Univ, Marseille viensp@ipc.unicancer.fr.
16: Department of Medical Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse-Oncopole,Toulouse, France.
Articles by these authors ⇆